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Background: Pleurotus sajor-caju (P. sajor-caju) has been extremely useful in the prevention of diabetes mellitus due
to its low fat and high soluble fiber content for thousands of years. Insulin resistance is a key component in the
development of diabetes mellitus which is caused by inflammation. In this study, we aimed to investigate the
in vivo efficacy of glucan-rich polysaccharide of P. sajor-caju (GE) against diabetes mellitus and inflammation in
C57BL/6J mice fed a high-fat diet.
Methods: Diabetes was induced in C57BL/6J mice by feeding a high-fat diet. The mice were randomly assigned to
7 groups (n=6 per group). The control groups in this study were ND (for normal diet) and HFD (for high-fat diet).
The treated groups were ND240 (for normal diet) (240 mg/kg b.w) and HFD60, HFD120 and HFD240 (for high-fat),
where the mice were administrated with three dosages of GE (60, 120, 240 mg GE/kg b.w respectively). Metformin
(2 mg/kg b.w) served as positive control. The glucose tolerance test, glucose and insulin levels were measured at
the end of 16 weeks. Expressions of genes for inflammatory markers, GLUT-4 and adiponectin in the adipose tissue
of the mice were assessed. One-way ANOVA and Duncan’s multiple range tests (DMRT) were used to determine the
significant differences between groups.
Results: GE treated groups improved the glucose tolerance, attenuated hyperglycemia and hyperinsulinemia in the
mice by up-regulating the adiponectin and GLUT-4 gene expressions. The mice in GE treated groups did not
develop insulin resistance. GE also down-regulated the expression of inflammatory markers (IL-6, TNF-α, SAA2, CRP
and MCP-1) via attenuation of nuclear transcription factors (NF-κB).
Conclusion: Glucan-rich polysaccharide of P. sajor-caju can serve as a potential agent for prevention of glucose
intolerance, insulin resistance and inflammation.
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Diabetes is one of the leading non-communicable dis-
eases affecting mankind [1]. It is estimated more than
284 million people are diabetic worldwide and this figure
is predicted to double by 2030 [2]. Diabetes mellitus
(DM) is a complicated metabolic disorder, characterised
by high blood glucose level due to the inability of cells
to utilise glucose appropriately. The etiology of type-1
diabetes is the absolute deficiency of insulin secretion,
while type 2 diabetes (DM) is a combination of resist-
ance to insulin action and impaired insulin secretion,
which accounts for more than 90% of all diabetes cases
[3]. Diabetes may lead to microvascular (blindness, renal
failure and neuropathy) and macrovascular (stroke and
myocardial infarction) complications [4]. It is also con-
sidered to be an important risk factor for the develop-
ment of obesity, hyperinsulinemia, hypertension,
dyslipidemia and atherosclerosis [5].
The current treatment for DM includes insulin and
other oral hypoglycemic drugs such as sulphonylurea
derivatives, biguanides, thiazolidinediones and alpha glu-
cosidase inhibitors. However, these agents are known to
have undesirable side effects such as high blood pres-
sure, dry mouth, constipation, headache, valvular heart
disease and obesity [6]. To date, natural products still
play an important role as sources of medicine in pre-
venting diabetes thus, the efforts to discover useful drug
candidates to combat diabetic complications are going
on relentlessly [7].
Mushrooms are well recognized for their medicinal
properties and have been used in traditional medicine
for centuries. The medicinal effects of mushrooms in-
clude antioxidant, antiviral, antibacterial, antifungal,
anti-parasitic, detoxification, immunomodulatory, antitu-
mor, radical scavenging, anti-inflammatory, cardiovascu-
lar, anti-hyperlipidemic or anti-hypercholesterolemic,
hepatoprotective and anti-diabetic [8]. Edible mush-
rooms have been used to maintain health and increase
longevity since ancient times [9]. In Malaysia, the widely
cultivated ‘edible fungal food’ is the genus Pleurotus,
commonly referred to as ‘oyster mushrooms’. Oyster
mushrooms have been discovered to have definite nutri-
tive and medicinal values and are most popular in coun-
tries such as India, China and Japan. Currently,
Pleurotus sajor-caju is cultivated throughout the world.
It contains good quality proteins and vitamins such as
B1, B2, and C and has very little lipid or starch. This
mushroom is claimed to be able to reduce the choles-
terol level in blood [10] and prevent hyperlipidemia and
this ability is attributed to its low fat and high soluble
fiber content [11].
There are two distinct animal models of obesity; the
first type is genetic obesity, as seen in rodent strains
such as the Zucker fatty (fa/fa) rat and the leptin-deficient obese (lepob/lepob) mouse, which become obese
under various experimental conditions. The second type
of mouse model for obesity, C57BL/6J reflects the
human condition more closely where the animals de-
velop central adiposity, hyperinsulinemia and hypergly-
cemia as a result of a combination of genetic and
environmental factors such as long term high-fat intake
[12]. Hence in this study, the C57BL/6J mouse strain
was selected to investigate the potential effects of
glucan-rich polysaccharides of P. sajor-caju in mice fed a
high fat-diet on metabolic changes pertaining to glucose
homeostasis and associated inflammation. The activity
was also compared with metformin (a widely used oral
anti-diabetic drug).Methods
Mushrooms samples
Fresh fruiting bodies of Pleurotus sajor –caju (10kg)
were collected from a mushroom farm in Semenyih (Lo-
cation - 3°21’19.20”N 101°14’36.35”E), Selangor Darul
Ehsan, Malaysia.
Isolation and purification of glucan-rich polysaccharide
from hot-aqueous extract of P. sajor-caju (GE)
The isolation and purification of polysaccharide were
based on the method described previously [13]. Fruiting
bodies of P. sajor-caju was collected and washed with
water. It was crushed and boiled in 500 ml of distilled
water for 8 hours. The whole mixture was kept over-
night at 4°C and then filtered through a linen cloth.
The filtrate was centrifuged at 13000 × g for 45 minutes
at 4°C. The supernatant was collected and precipitated
in ethanol (1:5 [v/v]). It was kept overnight at 4°C and
again centrifuged at 13000 × g for 45 minutes. The pre-
cipitated material (polysaccharide) was washed with
ethanol four times and then freeze-dried. The freeze-
dried material was dissolved in 30 ml of distilled water
and dialyzed through dialysis tubing made up of cellu-
lose membrane (Sigma-Aldrich, USA) against distilled
water for 4 hours. This procedure removed low molecu-
lar weight materials. The aqueous solution was then col-
lected from the dialysis bag and freeze-dried to yield
crude polysaccharide (GE). The β-glucan level in the ex-
tract was estimated using a ß - glucan kit (specific for
mushroom and yeast) purchased from Meganzyme
International (Ireland).
Animals
This study was conducted in conformity with the
policies and procedures of the Animal Care and Use
Committee of Faculty of Medicine, University of Malaya,
with reference to the 8th edition: Guide for the Care
and Use of Laboratory Animals by the Institute of
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Science, USA. The animal ethics approval was obtained
from Animal Care and Use Committee of Faculty of
Medicine, University of Malaya (IACUC, UM) (Approval
number:ISB/14/07/2010/GK [R]). Female C57BL/6J (ob/ob)
mice (7-weeks old) were purchased from BioLasco
Laboratory, Taiwan. The animals were kept in stainless
steel wire–mesh cages in a room maintained at 21°C and
a standard condition of 12-hour light/dark cycle (light
period: 8:00–20:00 hour). The animals were allowed free
access to food and water, which were provided fresh
every day.Experimental design
After one week of acclimatisation, the mice were ran-
domly assigned (based on weight) into seven groups
(n=6/group). Table 1 shows the type of diet and concen-
tration of GE administrated for each group. The control
groups in this study were ND (for normal diet) and HFD
(for high-fat diet), where the mice were administrated
with distilled water. The treated groups were ND240
(for normal diet) and HFD60, HFD120 and HFD240 (for
high-fat), where the mice were administrated with differ-
ent dosages of GE and metformin served as positive
control. The composition of fat in normal diet was 5% of
total energy whilst for the high-fat diet was 45 or 60% of
fat. GE was administered thrice a week, via epi-gastric
route using a feeding needle (size 20) to groups ND240,
HFD60, HFD120 and HFD240 for 16 weeks. After
7 weeks of feeding with 45% of fat (TestDietW, USA), the
animal diet was substituted with 60% of fat (TestDietW,
USA) for groups HFD, HFD60, HFD120, HFD240 and
HFDMET whilst for groups ND and ND240 the diet was
not altered throughout the experiment.
Oral Glucose Tolerance Test (OGTT)
At the end of 16 weeks, the oral glucose test was carried
out on the mice after subjecting to an overnight fast.
Blood samples were obtained from a cut in the tail vein
of the mice and blood glucose levels were determined
using ACCU-CHEKW glucometer and ACCU-CHEKWTable 1 Type of diet and concentration of GE administrated t
Type of diet Groups
Normal diet ND
ND240
HFD
HFD60
High-fat diet HFD120
HFD240
HFDMET HAdvantage test strips. Firstly, the fasting blood glucose
levels were measured. Then, GE was administrated to
the mice via epi-gastric route using a feeding needle and
the blood glucose levels was measured again. Glucose
(2 g/kg of body weight) was also administrated to the
mice via epi-gastric route. Finally, the blood glucose
levels were measured every 30 min for 2 hours (30, 60,
90 and 120 min). According to the protocol of the kit
and Lee et al., [14] mice with fasting blood glucose level
of 7.8 mmol/L (200 mg/dL) and above were considered
hyperglycemic meanwhile mice with fasting blood glu-
cose of below 3.9 mmol/L (70 mg/dL) was categorized
as hypoglycemic.Sample collection and analytical methods
At the end of 16 weeks, the mice were anesthetized with
ether after withholding food for 12 hours and were sacri-
ficed by aortic exsanguination. Blood samples were col-
lected in SST™ glass serum tubes with gold BD
Hemogard™ closure (BD VacutainerW, USA). Serum
samples were separated after centrifugation at 2400 × g
for 15 minutes. The samples were stored at −80°C for
the estimation of insulin level. Adipose tissues were
removed and stored in RNAlaterW solution (Applied
Biosystems, USA) and refrigerated at 4°C overnight be-
fore storing the samples at −80°C for RNA extraction.
Insulin Sensitivity Test
The insulin sensitivity assay was done using Rat Insulin
Enzyme Immunoassay kit (SPI-BIO Bertin pharma,
France). The assay is based on the competition between
unlabeled rat insulin and acethylcholinesterase (AChE)
linked to rat insulin (tracer) for limited specific Guinea-
Pig anti-rat insulin antiserum sites. The absorbance was
read at 410 nm using a microplate reader (Bio-Tek
Instruments Inc, USA). Rat insulin of known concentra-
tions (0.08 to 10 ng/ml) was used as a standard for the
estimation of insulin concentration and the results were
expressed as ng/ml.
The index of insulin resistance was estimated by
the homeostasis model assessment (HOMA) and waso each group
Treatment
Normal diet only + distilled H2O
Normal diet + 240 mg/kg of body weight GE
High-fat diet only + distilled H2O
High-fat diet + 60 mg/kg of body weight of GE
High-fat diet + 120 mg/kg of body weight of GE
High-fat diet + 240 mg/kg of body weight of GE
igh-fat diet + 2 mg/kg of body weight of metformin (anti-diabetic drug)
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and insulin levels according to the following formula [15]:
HOMA IR ¼ Insulin μUI=Lð Þ  Blood glucose mmol=Lð Þ
22:5
Gene expression studies using Real Time – RT-PCR
The total RNA was isolated from the adipose tissue of all
the mice groups as stipulated in Table 1 using Ambion-
RNAqueous MicroW kit (Applied Biosystems, USA). The
purity of recovered total RNA was estimated by calculat-
ing the ratio of absorbance reading of 260 nm and
280 nm. Purified RNA with a A260/A280 ratio between
1.8 - 2.0 was further used to synthesize complementary
DNA (cDNA) by polymerase chain reaction (PCR)
approach. The integrity of RNA was estimated using Agi-
lentW 2100 Bioanalyzer (Applied Biosystem, USA). RNA
samples with RIN value 8–10 were used in this study.
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystem, USA) which contains all reagents needed for
reverse transcription (RT) of total RNA to single-stranded
cDNA was used in this study. Generally, 10 μl of RNA
sample was mixed with 10 μl of High Capacity cDNA
Reverse Transcription (RT buffer, dNTP mix, randoms
primers, Multiscribe reverse™ transcriptase enzyme and
nuclease free water). The mixture was then loaded into a
thermal cycler (Eppendorf, USA) and PCR was carried
out according to optimized thermal cycling conditions as
recommended by the manufacturer. Table 2 shows the list
of genes investigated in this study and the corresponding
accession numbers. Endogenous control (also known as
housekeeping genes) used in this study was eukaryotic
18S rRNA with FAM/MGB probe. All TaqManW (Applied
Biosystems, USA) probes used in this investigation were
labeled with FAM™ reporter dye at the 5’ end and MGB
quencher at the 3’ end. The quantification approach used
was comparative CT method, also known as 2
–ΔΔCt
method [16].
Statistical analysis
Data are shown as mean ± SD of triplicate assays. One-
way analysis of variance was used to determine the
significant differences between groups. Statistical signifi-
cance was accepted at p < 0.05. Duncan’s multiple range
tests (DMRT) was used to determine the significant dif-
ferences between groups. SPSS Statistic software (version
17.0, IBM Corp., USA) was used for all statistical ana-
lyses. All figures were drawn using GraphPad Prism 5
(GraphPad Software Inc., California, USA).
Results and discussion
Weight and estimation of β-glucan concentration in GE
GE (12.31g) was obtained from 5500g of fresh P. sajor-
caju fruiting bodies. This extract was then used tocalculate the content of β-glucan by measuring the
concentration of total glucan and α-glucan. The con-
centration of total glucan in GE was 85.95% (w/w)
and the concentrations of α-glucan and β-glucan were
5.4% (w/w) and 80.55% (w/w) respectively. The percent-
age of β-glucan and α-glucan in dried P. sajor-caju were
1.5% and 0.01% (w/w) respectively. In this study, a
detailed analysis of the sugar composition and lingkages
was not attempted but Pramanik et al. [17], reported that
the polysaccharides in P.sajor-caju consists of repeating
unit of D-glucose, D-galactose, and D-mannose in a
molar proportion of 1:1:1 with (1→3),(1→6)-β-glucans
and (1→3)-α-glucans linkages.Effects of GE on glucose tolerance
The glucose tolerance test was performed on the mice.
Figure 1 shows the oral glucose tolerance test results of
all the groups. Mice in HFD and HFD60 groups had ele-
vated fasting blood glucose level and reduced glucose
tolerance. In GE treated mice (ND240, HFD120 and
HFD240), the glucose level in the first 30 minutes (after
the initial glucose load) were lower than HFD while the
glucose level at 120 minutes was within the normal
range and the activity was similar to the metformin trea-
ted group (HFDMET). The blood glucose tolerance level
in descending order was ND240 > HFD240 > ND >
HFD120 > HFDMET > HFD60 > HFD.Effects of GE on blood glucose, serum insulin levels and
insulin resistance index
Systemic inflammation has been recognized as a key link
between insulin resistance and diabetes [18]. Insulin re-
sistance is characterized by increased expression of pro-
inflammatory cytokines, macrophage infiltration into
white adipose tissue and an impaired response to insulin
in the main insulin target tissues.
Figure 2 (a-c) shows the effect of GE and metformin
on blood glucose levels, serum insulin concentration and
HOMA-IR value in mice fed a high-fat diet or normal
diet. The fasting blood glucose in descending order was
HFD > HFD60 > HFDMET > HFD > ND > HFD120 >
HFD240 > ND240. A moderate but significant hypergly-
cemia developed in HFD group. Severe hyperglycemia
and hyperinsulinemia in C57BL/6J mice are only known
to develop after 24 weeks of feeding with high-fat diet
[19]. GE administrated mice (HFD120 and HFD240)
showed a significantly lower fasting blood glucose levels
compared to the mice in HFD group. Nevertheless, there
were no significant differences observed in the normal
diet groups (ND and ND240). The serum insulin level
was significantly elevated in HFD group and was 88.8%
higher than the ND group which indicates hyperinsuli-
nemia. However, GE treated groups and metformin
Table 2 Genes investigated
No Gene name and abbreviation Assay ID Accession number
1 Adiponectin Mm 00456425_m1 NM_009605.4
2 Glucose transporter Mm 00436615_m1 NM_009204.2
(GLUT-4)
3 Retinol binding protein 4 Mm 00803266_m1 XM_993476
(RBP-4)
4 Nuclear factor-κB Mm 00482418_m1 NM_003998
(NF-κB)
5 Tumor necrosis factor-α Mm 00443258_m1 NM_013693.2
(TNF-α)
6 Serum amyloid A 2 Mm 00656927_g1 NM_009117.3
(SAA-2)
7 Interleukin 6 Mm 00446190_m1 NM_031168.1
(IL-6)
8 Monocyte chemoattractant protein-1 Mm 00437433_m1 NM_011331.2
(MCP-1)
9 C-reactive proteins Mm 00432680_g1 NM_007768.4
(CRP)
General abbreviation of genes selected for this study and corresponding assay ID and accession number was obtained from the Applied Biosystems website and
NCBI database. Assay ID refers to the Applied Biosystems Gene Expression Assays inventoried kits with proprietary primer and TaqManW probe mix. Assay ID with
‘Mm’ is referred to as ‘Mus musculus’. All Gene Expression Assay kits indicated are FAM/MGB probed.
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concentration compared to HFD group.
Homeostatic model assessment values for insulin re-
sistance (HOMA-IR) were calculated using the formula
stated above. The HOMA-IR indices for the HFD group
showed an increase of 150% compared to ND group. In
spite of feeding a high-fat diet, the insulin resistance in-
dices for HFD60, HFD120 and HFD240 groups were sig-
nificantly reduced by 44%, 62.4% and 60.8% respectively
whilst in HFDMET group, the insulin resistance index-30 0 30 6
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Figure 1 Effects of GE on oral glucose tolerance (OGT) in C57BL/6J m
120, 240 mg/kg/day. Metformin (MET) was used as positive control. Blood g
(−30 min) and every 30 minutes after glucose administration (0, 30, 60, 90,
measurements (n=6 per group).was significantly reduced by 56% compared to HFD
group. Amelioration of insulin resistance in HFD240
treated group was comparable to the metformin treated
group. Thus it is pertinent to suggest that GE was able
to prevent hyperglycemia by preventing insulin resist-
ance in the mice fed a high-fat diet.
Reactive oxygen species (ROS) production is one of
the many factors that have been suggested to play a role
in the development of insulin resistance [19,20]. Nagata
et al. [21] have demonstrated that up-regulation of genes0 90 120
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Figure 2 Effects of GE on (a) fasting blood glucose concentrations, (b) serum insulin levels and (c) HOMA-IR value of C57BL/6J mice
fed a high-fat diet or normal diet. GE concentrations were 60, 120, 240 mg/kg/day. Metformin (MET) was used as positive control. Values
expressed are means ± S.D of triplicate measurements (n=6 per group). Means with different alphabets in different bar (a-e) are significantly
different (p<0.05).
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liver and adipose tissue before the onset of insulin resist-
ance in mice fed a high fat-diet.Effects of GE on the expression of adipokines and
inflammatory markers in adipose tissue
Adipose tissue is actively involved in sensing the nutri-
tional and metabolic status of the organism through sev-
eral signalling pathways and the energy metabolism is
regulated by the secretion of molecules in response to
these cues [22]. It is a complex and active secretory
organ that both sends and receives signals that modulateenergy expenditure, appetite, insulin sensitivity, endo-
crine function, inflammation and immunity [23]. Thus,
this part of the study, attempts to increase the under-
standing of how GE possibly regulates the underlying
mechanism responsible for hypoglycemia, amelioration
of insulin resistance and the associated inflammation.
Table 3 shows the expression of adipocyte derived cyto-
kines (adipokines).
After 15 weeks of feeding a high-fat diet, HFD group
mice developed hyperglycemia and had reduced glucose
tolerance (Figure 1). This could be attributed to the
reduced expression of adiponectin. Meanwhile, GE trea-
ted groups (HFD120 and HFD240) had increased
Table 3 Effects of GE on the expression of adipokines in adipose tissue
Genes investigated ND240 HFD60 HFD120 HFD240 HFDMET
GLUT-4 1.49±0.24 1.78±0.3bd 2.41±0.42b 2.05±0.32a 1.13±0.13c
Adiponectin 1.56±0.15 0.81±0.37c 1.13±0.62b 1.68±0.30a 1.66±0.24a
RBP-4 0.10±0.13 −1.20±0.16b −1.30±0.44b −1.63±0.33a −1.50±0.17a
Results are expressed as –fold variation over the appropriate control groups; ND240 indicate fold increase over ND, normal diet control group and HFD60,
HFD120, HFD240 and HFDMET indicate fold increase over HFD, high-fat diet control group. Fold variations less than one were expressed as negative numbers
(e.g., a –fold variation of 0.50 is expressed as −2.00). Values expressed are means ± S.D of triplicate measurements. Statistical significance was calculated based on
the mean ΔCT values by DMRT for only mice fed with high-fat diet with or without GE. For same gene with different treatment groups, means in the different
rows with different alphabets (a-d) were significantly different (p<0.05).
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glucose tolerance observed in these groups. Adiponectin
is considered to be an anti-diabetic and anti-atherogenic
hormone, but conflicting results on its levels in obese
and diabetic patients and animal models have been
shown in previous studies [24]. Some of them demon-
strated declined circulating levels of adiponectin in high-
fat diet fed rats [25] and mice [26] while others did not
observe any changes [27,28]. A possible explanation for
such difference is that the expression of adiponectin,
could be altered by multiple factors including both gen-
etic and environmental factors, as well as resting and
fasting stages [29]. Meanwhile, GLUT-4 gene, the
insulin-responsive glucose transporter, plays a major role
in glucose transport. The maintenance of insulin sensi-
tivity in adipose tissue and the development of insulin
resistance (IR) is a result of impaired GLUT-4 signalling
pathway [30]. In this study, the mice in GE treated
groups, showed better glucose tolerance than the mice
in HFD group, and the improvement in glucose toler-
ance was also reflected by the increased GLUT-4 expres-
sion in these groups.
On the contrary, RBP-4 has been reported as a factor
that is derived from adipose tissue that can cause insulin
resistance [31]. The mechanism of RBP-4 activation is
still unclear but several reports have shown that
increased expression of RBP-4 was found in adipose tis-
sue of mice with adipocyte-specific ablation of GLUT-4
[32]. Increased plasma RBP-4 levels in obese children
correlated not only with insulin resistance but also with
inflammatory factors [33]. This concurs with the find-
ings in this study that, GE treated groups (HFD60,
HFD120 and HFD240) had decreased expression of
RPB-4 compared to HFD group. In HFDMET group, the
regulation of these adipokines was similar to the GE
treated groups.
The expressions of inflammatory markers (IL-6, CRP,
MCP-1, SAA-2, NF-κB and TNF-α) were also assessed
in the adipose tissue as shown in Table 4. The link be-
tween diabetes mellitus, insulin resistance and inflam-
mation are well known [34] and epidemiological
evidence has confirmed these findings by showing an in-
crease of additional acute phase reactants in diabetic
subjects, including TNF-α, IL-6 and CRP [35]. Glucoseand fat intake have both been shown to induce inflam-
mation, possibly due to increase of oxidative stress [36].
Nuclear factor-κB (NF-κB) controls the regulation of
the genes that encode proteins involved in immune and
inflammatory responses (i.e., cytokines, chemokines,
growth factor immune receptors, cellular ligands, and
adhesion molecules) [37]. Diabetes causes reduction in
the production of anti-inflammatory adipokines (like
adiponectin) and increase in the production of pro-
inflammatory cytokines (like IL-6, CRP and SAA-2).
This, in turn, leads to the MCP-1 facilitated infiltration
of monocytes and macrophages into the adipose tissue
[38]. The inflamed state leads to the release of cytokines
into adipose tissues that are not normally secreted by
the adipose cells. A key cytokine that is released by
macrophages but not by differentiated adipocyte, is
TNF-α, the key regulator of inflammation which is
strongly correlated to the level of insulin resistance in
obese and diabetic animal models [39]. Studies have
demonstrated that, TNF-α along with IL-6 not only in-
hibit adiponectin (anti-inflammatory adipokines) expres-
sion and impair insulin sensitivity of other tissues but
also interfere with adipocyte metabolism at numerous
sites including transcriptional regulation, glucose and
fatty acid metabolism [40]. The pro-inflammatory cyto-
kine IL-6 was among the first to be implicated as
a predictor of insulin resistance. Finally, these pro-
inflammatory cytokines (IL-6 and TNF-α) mediate dis-
tant inflammatory effects, including activation of CRP
and SAA-2 [41]. The SAA proteins are derived from dis-
tinct genes; human express SAA-1, SAA-2, SAA-3 and
SAA-4. In this study, only SAA-2 protein was studied
because SAA-2 expression increases dramatically during
acute inflammatory responses and adipocytes have been
suggested to be a major contributor of SAA-2 [23].
Meanwhile, CRP is an acute phase reactant. Circulating
concentrations of SAA-2 and CRP are also increased in
individuals with impaired glucose tolerance and are con-
sidered to be a marker for insulin resistance [42].
The HFD group had higher expression of the pro-
inflammatory markers compared to the GE treated
groups and metformin treated group. ROS and endo-
plasmic reticulum (ER) stress have been reported to be
increased by adiposity and consumption of high-fat diet
Table 4 Effects of GE on the expression of inflammatory markers in adipose tissue
Genes investigated ND240 HFD60 HFD120 HFD240 HFDMET
IL-6 −1.17±0.67 −1.38±0.41c −1.11±0.20d −3.27±0.92b −1.35±0.03c
CRP −2.10±0.60 0.10±0.78a −4.00±0.21b −3.40±0.87b −2.30±0.12c
MCP-1 −1.63±0.45 1.09±0.14b −2.33±0.24c −1.33±0.69d −1.20±1.10d
SAA-2 −1.55±0.66 −5.53±0.47b −5.39±0.54b −5.67±0.95b −3.82±0.77c
NF-κB −1.11±0.37 −2.30±0.29b −2.90±0.92c −2.30±0.30b −2.45±1.13b
TNF-α −3.46±0.09 1.16±0.21b −4.50±0.43c −4.11±0.37c −1.79±1.06d
Results are expressed as –fold variation over the appropriate control groups; ND240 indicate fold increase over ND, normal diet control group and HFD60,
HFD120, HFD240 and HFDMET indicate fold increase over HFD, high-fat diet control group. Fold variations less than one were expressed as negative numbers (e.
g., a –fold variation of 0.50 is expressed as −2.00). Values expressed are means ± S.D of triplicate measurements. Statistical significance was calculated based on
the mean ΔCT values by DMRT for only mice fed with high-fat diet with or without GE. For same gene with different treatment groups, means in the different
rows with different alphabets (a-d) were significantly different (p<0.05).
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http://www.biomedcentral.com/1472-6882/12/261may activate NF-κB signalling cascade in the adipose tis-
sue [23]. When NF-κB signaling cascade is activated,
increased MCP-1 results in a dramatic elevation of
macrophage infiltration, promoting the downstream se-
cretion of pro-inflammatory markers namely, TNF-α
and IL-6 and finally this increases the expression of CRP
and SAA-2. The expression of these pro-inflammatory
markers in HFD, are known to initiate and amplify insu-
lin resistance in the adipose tissue as observed in this
study. However, the NF-κB activity in GE and metformin
treated groups, was significantly down-regulated com-
pared to the HFD group. Thus, the expression of TNF-α
and IL-6 also decreased in these groups. Similarly, the
expressions of SAA-2 and CRP were also down-
regulated in GE and metformin treated groups compared
to HFD group. Besides that, the local enhancement in
adiponectin expression induced by GE might also be
partly responsible for the reduced inflammatory-cytokine
expression levels in these groups [39]. Similar findings
have been reported on adipose tissue treated with various
natural substances such as grape seed procyanidins [38]
and tocotrienol [37].
Conclusion
Polysaccharide of P. sajor-caju which is rich in β-glucans
(GE) (240mg/kg of body weight) prevented the occur-
rence of glucose intolerance, hyperglycemia and hyperin-
sulinemia/insulin resistance in C57BL/6J mice fed a
high-fat diet by up-regulating the expression of GLUT-4
and adiponectin genes and down-regulating the expres-
sion of NF-κB. The properties displayed by GE were
comparable to metformin (positive control). GE could
serve as a potential candidate for prevention of glucose
intolerance, insulin resistance and inflammation.
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